Cell and Tissue Research

, Volume 369, Issue 3, pp 527–539 | Cite as

MicroRNA-27a/b mediates endothelin-1-induced PPARγ reduction and proliferation of pulmonary artery smooth muscle cells

  • Xinming Xie
  • Shaojun Li
  • Yanting Zhu
  • Lu Liu
  • Yilin Pan
  • Jian Wang
  • Wenhua Shi
  • Yang Song
  • Lan Yang
  • Li Gao
  • Weijin Zang
  • Manxiang LiEmail author
Regular Article


The down-regulation of peroxisome proliferator-activated receptor γ (PPARγ) expression has been found to correlate with the proliferation of pulmonary artery smooth muscle cells (PASMC), pulmonary vascular remodeling and pulmonary hypertension, while the molecular mechanisms underlying PPARγ reduction in PASMC remain largely unclear. The aim of the current study is to address this issue. Endothelin-1 (ET-1) dose- and time-dependently resulted in PPARγ reduction and proliferation of primary cultured rat PASMC, which was accompanied by the activation of nuclear factor-kappaB (NF-κB) and subsequent induction of microRNA-27a/b (miR-27a/b) expression. Chromatin immunoprecipitation assay revealed that NF-κB directly bound to the promoter regions of miR-27a/b. Luciferase reporter assay identified that miR-27a/b directly regulates the expression of PPARγ in PASMC. Further study indicated that the presence of either NF-κB inhibitor pyrrolidinedithiocarbamate or prior silencing miR-27a/b with anti-miRNA oligonucleotides suppressed ET-1-induced PPARγ reduction and proliferation of PASMC, while overexpression of miR-27a/b reduced PPARγ expression and enhanced PASMC proliferation. Taken together, our study demonstrates that ET-1 stimulates miR-27a/b expression by activation of the NF-κB pathway, which in turn results in PPARγ reduction and contributes to ET-1-induced PASMC proliferation.


Endothelin-1 Nuclear factor-kappaB miR-27a/b Peroxisome proliferator-activated receptor γ Pulmonary artery smooth muscle cells Pulmonary hypertension 





Chromatin immunoprecipitation


Dulbecco’s Modified Eagle Medium


Endothelial cell


Ethylene diamine tetraacetic acid




Fetal bovine serum


Glyceraldehyde-3-phosphate dehydrogenase




Negative control


Nuclear factor-kappaB


Nonidet P-40


Pulmonary arterial endothelial cells


Pulmonary hypertension


Pulmonary arterial pressure


Pulmonary artery smooth muscle cells


Polymerase chain reaction


Pyrrolidine dithiocarbamate


Phenylmethylsulfonyl fluoride


Peroxisome proliferator-activated receptor γ


Sodium dodecyl sulfate


Untranslated region



This study was supported by the National Natural Science Foundation of China (Grant No. 81070045).

Compliance with ethical standards

The funders of this project had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests

The authors have declared no conflict of interest.


  1. Ackerman WET, Zhang XL, Rovin BH, Kniss DA (2005) Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells. Biol Reprod 73:527–535CrossRefPubMedPubMedCentralGoogle Scholar
  2. Ameshima S, Golpon H, Cool CD, Chan D, Vandivier RW, Gardai SJ, Wick M, Nemenoff RA, Geraci MW, Voelkel NF (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 92:1162–1169CrossRefPubMedGoogle Scholar
  3. Au SL, Wong CC, Lee JM, Wong CM, Ng IO (2013) EZH2-mediated H3K27me3 is involved in epigenetic repression of deleted in liver cancer 1 in human cancers. PLoS ONE 8:e68226CrossRefPubMedPubMedCentralGoogle Scholar
  4. Ban JO, Oh JH, Son SM, Won D, Song HS, Han SB, Moon DC, Kang KW, Song MJ, Hong JT (2011) Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFkappaB via suppression of GSK-3beta expression. Cancer Biol Ther 12:288–296CrossRefPubMedGoogle Scholar
  5. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297CrossRefPubMedGoogle Scholar
  6. Bazan IS, Fares WH (2015) Pulmonary hypertension: diagnostic and therapeutic challenges. Ther Clin Risk Manag 11:1221–1233PubMedPubMedCentralGoogle Scholar
  7. Bi R, Bao C, Jiang L, Liu H, Yang Y, Mei J, Ding F (2015) MicroRNA-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor gamma dependent Hsp90-eNOS signaling and nitric oxide production. Biochem Biophys Res Commun 460:469–475CrossRefPubMedGoogle Scholar
  8. Bijli KM, Kleinhenz JM, Murphy TC, Kang BY, Adesina SE, Sutliff RL, Hart CM (2015) Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation. Free Radic Biol Med 80:111–120CrossRefPubMedGoogle Scholar
  9. Brock M, Haider TJ, Vogel J, Gassmann M, Speich R, Trenkmann M, Ulrich S, Kohler M, Huber LC (2015) The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A. Int J Biochem Cell Biol 61:129–137CrossRefPubMedGoogle Scholar
  10. Caruso P, MacLean MR, Khanin R, McClure J, Soon E, Southgate M, MacDonald RA, Greig JA, Robertson KE, Masson R, Denby L, Dempsie Y, Long L, Morrell NW, Baker AH (2010) Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 30:716–723CrossRefPubMedGoogle Scholar
  11. Chang AJ, Song DH, Wolfe MM (2006) Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation. J Biol Chem 281:14700–14710CrossRefPubMedGoogle Scholar
  12. Chintharlapalli S, Papineni S, Abdelrahim M, Abudayyeh A, Jutooru I, Chadalapaka G, Wu F, Mertens-Talcott S, Vanderlaag K, Cho SD, Smith R 3rd, Safe S (2009) Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells. Int J Cancer 125:1965–1974CrossRefPubMedPubMedCentralGoogle Scholar
  13. Crossno JT Jr, Garat CV, Reusch JE, Morris KG, Dempsey EC, McMurtry IF, Stenmark KR, Klemm DJ (2007) Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling. Am J Physiol Lung Cell Mol Physiol 292:L885–L897CrossRefPubMedGoogle Scholar
  14. de Vroomen M, Lopes Cardozo RH, Steendijk P, Frolich M, Baan J, van Bel F (2001) Endothelin-1 plasma concentration increases in the early phase of pulmonary hypertension development during respiratory distress syndrome: a study in newborn lambs. Early Hum Dev 63:9–21CrossRefPubMedGoogle Scholar
  15. Di ZL, Niu XL, Wei J, Gao DF, Wang NP (2005) Effect of endothelin-1 stimulation on peroxisome proliferator-activated receptor-gamma expression in vascular smooth muscle cells. Di Yi Jun Yi Da Xue Xue Bao 25:1140–1144PubMedGoogle Scholar
  16. Fang YC, Yeh CH (2015) Role of microRNAs in vascular remodeling. Curr Mol Med 15:684–696CrossRefPubMedPubMedCentralGoogle Scholar
  17. Fiorillo AA, Heier CR, Novak JS, Tully CB, Brown KJ, Uaesoontrachoon K, Vila MC, Ngheim PP, Bello L, Kornegay JN, Angelini C, Partridge TA, Nagaraju K, Hoffman EP (2015) TNF-alpha-induced microRNAs control dystrophin expression in Becker muscular dystrophy. Cell Rep 12:1678–1690CrossRefPubMedPubMedCentralGoogle Scholar
  18. Fukuda K, Matsumura T, Senokuchi T, Ishii N, Kinoshita H, Yamada S, Murakami S, Nakao S, Motoshima H, Kondo T, Kukidome D, Kawasaki S, Kawada T, Nishikawa T, Araki E (2015) Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-gamma activation. Biochem Biophys Res Commun 457:23–30CrossRefPubMedGoogle Scholar
  19. Gao D, Hao G, Meng Z, Ning N, Yang G, Liu Z, Dong X, Niu X (2015) Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells. PLoS ONE 10:e0123724CrossRefPubMedPubMedCentralGoogle Scholar
  20. Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl):S81–S96CrossRefPubMedGoogle Scholar
  21. Gien J, Tseng N, Seedorf G, Roe G, Abman SH (2014) Peroxisome proliferator activated receptor-gamma-rho-kinase interactions contribute to vascular remodeling after chronic intrauterine pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 306:L299–L308CrossRefPubMedGoogle Scholar
  22. Green DE, Murphy TC, Kang BY, Kleinhenz JM, Szyndralewiez C, Page P, Sutliff RL, Hart CM (2012) The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. Am J Respir Cell Mol Biol 47:718–726CrossRefPubMedPubMedCentralGoogle Scholar
  23. Guignabert C, Alvira CM, Alastalo TP, Sawada H, Hansmann G, Zhao M, Wang L, El-Bizri N, Rabinovitch M (2009) Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization. Am J Physiol Lung Cell Mol Physiol 297:L1082–L1090CrossRefPubMedPubMedCentralGoogle Scholar
  24. Han X, Chen C, Cheng G, Liang L, Yao X, Yang G, You P, Shou X (2015) Peroxisome proliferator-activated receptor gamma attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway. Microvasc Res 100:17–24CrossRefPubMedGoogle Scholar
  25. Hansmann G, de Jesus Perez VA, Alastalo TP, Alvira CM, Guignabert C, Bekker JM, Schellong S, Urashima T, Wang L, Morrell NW, Rabinovitch M (2008) An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 118:1846–1857CrossRefPubMedPubMedCentralGoogle Scholar
  26. Hosokawa S, Haraguchi G, Sasaki A, Arai H, Muto S, Itai A, Doi S, Mizutani S, Isobe M (2013) Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354. Cardiovasc Res 99:35–43CrossRefPubMedGoogle Scholar
  27. Huang J, Kaminski PM, Edwards JG, Yeh A, Wolin MS, Frishman WH, Gewitz MH, Mathew R (2008) Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. Am J Physiol Lung Cell Mol Physiol 294:L1250–L1259CrossRefPubMedPubMedCentralGoogle Scholar
  28. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jais X, Montani D, Souza R, Simonneau G (2010) Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122:156–163CrossRefPubMedGoogle Scholar
  29. Humbert M, Sitbon O, Simonneau G (2004) Treatment of pulmonary arterial hypertension. N Engl J Med 351:1425–1436CrossRefPubMedGoogle Scholar
  30. Jennewein C, von Knethen A, Schmid T, Brune B (2010) MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. J Biol Chem 285:11846–11853CrossRefPubMedPubMedCentralGoogle Scholar
  31. Jin D, Tao J, Li D, Wang Y, Li L, Hu Z, Zhou Z, Chang X, Qu C, Zhang H (2015a) Golgi protein 73 activation of MMP-13 promotes hepatocellular carcinoma cell invasion. Oncotarget 6:33523–33533CrossRefPubMedPubMedCentralGoogle Scholar
  32. Jin H, Gebska MA, Blokhin IO, Wilson KM, Ketsawatsomkron P, Chauhan AK, Keen HL, Sigmund CD, Lentz SR (2015b) Endothelial PPAR-gamma protects against vascular thrombosis by downregulating P-selectin expression. Arterioscler Thromb Vasc Biol 35:838–844CrossRefPubMedPubMedCentralGoogle Scholar
  33. Kang BY, Park KK, Green DE, Bijli KM, Searles CD, Sutliff RL, Hart CM (2013) Hypoxia mediates mutual repression between microRNA-27a and PPARgamma in the pulmonary vasculature. PLoS ONE 8:e79503CrossRefPubMedPubMedCentralGoogle Scholar
  34. Ke R, Liu L, Zhu Y, Li S, Xie X, Li F, Song Y, Yang L, Gao L, Li M (2016) Knockdown of AMPKalpha2 promotes pulmonary arterial smooth muscle cells proliferation via mTOR/Skp2/p27(Kip1) signaling pathway. Int J Mol Sci 17:844Google Scholar
  35. Keller RL, Tacy TA, Hendricks-Munoz K, Xu J, Moon-Grady AJ, Neuhaus J, Moore P, Nobuhara KK, Hawgood S, Fineman JR (2010) Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. Am J Respir Crit Care Med 182:555–561CrossRefPubMedPubMedCentralGoogle Scholar
  36. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5:104–112CrossRefPubMedGoogle Scholar
  37. Kim EK, Lee JH, Oh YM, Lee YS, Lee SD (2010a) Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats. Respirology 15:659–668CrossRefPubMedGoogle Scholar
  38. Kim SY, Kim AY, Lee HW, Son YH, Lee GY, Lee JW, Lee YS, Kim JB (2010b) miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 392:323–328CrossRefPubMedGoogle Scholar
  39. Kojonazarov B, Isakova J, Imanov B, Sovkhozova N, Sooronbaev T, Ishizaki T, Aldashev AA (2012) Bosentan reduces pulmonary artery pressure in high altitude residents. High Altitude Med Biol 13:217–223CrossRefGoogle Scholar
  40. Kollipara RK, Kittler R (2015) An integrated functional genomic analysis identifies the antitumorigenic mechanism of action for PPARgamma in lung cancer cells. Genom Data 3:80–86CrossRefPubMedGoogle Scholar
  41. Kwon YS, Chi SY, Shin HJ, Kim EY, Yoon BK, Ban HJ, Oh IJ, Kim KS, Kim YC, Lim SC (2010) Plasma C-reactive protein and endothelin-1 level in patients with chronic obstructive pulmonary disease and pulmonary hypertension. J Korean Med Sci 25:1487–1491CrossRefPubMedPubMedCentralGoogle Scholar
  42. Li L, Wei C, Kim IK, Janssen-Heininger Y, Gupta S (2014) Inhibition of nuclear factor-kappaB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice. Hypertension 63:1260–1269CrossRefPubMedGoogle Scholar
  43. Li M, Li Z, Sun X, Yang L, Fang P, Liu Y, Li W, Xu J, Lu J, Xie M, Zhang D (2010) Heme oxygenase-1/p21WAF1 mediates peroxisome proliferator-activated receptor-gamma signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells. FEBS J 277:1543–1550CrossRefPubMedGoogle Scholar
  44. Li S, Li J, Fei BY, Shao D, Pan Y, Mo ZH, Sun BZ, Zhang D, Zheng X, Zhang M, Zhang XW, Chen L (2015) MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target Gene peroxisome proliferator-activated receptor gamma. Chin Med J 128:941–947CrossRefPubMedPubMedCentralGoogle Scholar
  45. Lin Q, Gao Z, Alarcon RM, Ye J, Yun Z (2009) A role of miR-27 in the regulation of adipogenesis. FEBS J 276:2348–2358CrossRefPubMedPubMedCentralGoogle Scholar
  46. Liu S, Yang Y, Wu J (2011) TNFalpha-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors. Biochem Biophys Res Commun 414:618–624CrossRefPubMedGoogle Scholar
  47. Liu T, Tang H, Lang Y, Liu M, Li X (2009) MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 273:233–242CrossRefPubMedGoogle Scholar
  48. Liu Y, Tian XY, Huang Y, Wang N (2014) Rosiglitazone attenuated endothelin-1-induced vasoconstriction of pulmonary arteries in the rat model of pulmonary arterial hypertension via differential regulation of ET-1 receptors. PPAR Res 2014:374075CrossRefPubMedPubMedCentralGoogle Scholar
  49. Liu Y, Tian XY, Mao G, Fang X, Fung ML, Shyy JY, Huang Y, Wang N (2012) Peroxisome proliferator-activated receptor-gamma ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor. Hypertension 60:1471–1478CrossRefPubMedGoogle Scholar
  50. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–408CrossRefPubMedGoogle Scholar
  51. Lu X, Bijli KM, Ramirez A, Murphy TC, Kleinhenz J, Hart CM (2013) Hypoxia downregulates PPARgamma via an ERK1/2-NF-kappaB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells. Free Radic Biol Med 63:151–160CrossRefPubMedPubMedCentralGoogle Scholar
  52. Lu X, Murphy TC, Nanes MS, Hart CM (2010) PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B. Am J Physiol Lung Cell Mol Physiol 299:L559–L566CrossRefPubMedPubMedCentralGoogle Scholar
  53. Luo S, Wang J, Ma Y, Yao Z, Pan H (2015) PPARgamma inhibits ovarian cancer cells proliferation through upregulation of miR-125b. Biochem Biophys Res Commun 462:85–90CrossRefPubMedGoogle Scholar
  54. Lv J, Qiu M, Xia W, Liu C, Xu Y, Wang J, Leng X, Huang S, Zhu R, Zhao M, Ji F, Xu L, Xu K, Yin R (2016) High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer. J Exp Clin Cancer Res: CR 35:75CrossRefPubMedPubMedCentralGoogle Scholar
  55. Mansure JJ, Nassim R, Chevalier S, Szymanski K, Rocha J, Aldousari S, Kassouf W (2013) A novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancer. PLoS ONE 8:e55997CrossRefPubMedPubMedCentralGoogle Scholar
  56. Matsuda Y, Hoshikawa Y, Ameshima S, Suzuki S, Okada Y, Tabata T, Sugawara T, Matsumura Y, Kondo T (2005) Effects of peroxisome proliferator-activated receptor gamma ligands on monocrotaline-induced pulmonary hypertension in rats. Nihon Kokyuki Gakkai Zasshi 43:283–288PubMedGoogle Scholar
  57. Milenkovic D (2014) MicroRNAs as novel nutrigenomic targets for cardiovascular health. Free Radic Biol Med 75(Suppl 1):S11CrossRefPubMedGoogle Scholar
  58. Monaco C, Andreakos E, Kiriakidis S, Mauri C, Bicknell C, Foxwell B, Cheshire N, Paleolog E, Feldmann M (2004) Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci U S A 101:5634–5639CrossRefPubMedPubMedCentralGoogle Scholar
  59. Pellerito O, Notaro A, Sabella S, De Blasio A, Vento R, Calvaruso G, Giuliano M (2014) WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARgamma down-regulation. Apoptosis 19:1029–1042PubMedGoogle Scholar
  60. Rahman A, Fazal F (2011) Blocking NF-kappaB: an inflammatory issue. Proc Am Thorac Soc 8:497–503CrossRefPubMedPubMedCentralGoogle Scholar
  61. Sawada H, Mitani Y, Maruyama J, Jiang BH, Ikeyama Y, Dida FA, Yamamoto H, Imanaka-Yoshida K, Shimpo H, Mizoguchi A, Maruyama K, Komada Y (2007) A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. Chest 132:1265–1274CrossRefPubMedGoogle Scholar
  62. Song Y, Wu Y, Su X, Zhu Y, Liu L, Pan Y, Zhu B, Yang L, Gao L, Li M (2016) Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms. Pharmacol Res 107:117–124CrossRefPubMedGoogle Scholar
  63. Stewart DJ, Levy RD, Cernacek P, Langleben D (1991) Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 114:464–469CrossRefPubMedGoogle Scholar
  64. Wolf D, Tseng N, Seedorf G, Roe G, Abman SH, Gien J (2014) Endothelin-1 decreases endothelial PPARgamma signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 306:L361–L371CrossRefPubMedGoogle Scholar
  65. Wu Y, Liu L, Zhang Y, Wang G, Han D, Ke R, Li S, Feng W, Li M (2014) Activation of AMPK inhibits pulmonary arterial smooth muscle cells proliferation. Exp Lung Res 40:251–258CrossRefPubMedGoogle Scholar
  66. Xie X, Wang G, Zhang D, Zhang Y, Zhu Y, Li F, Li S, Li M (2015) Activation of peroxisome proliferator-activated receptor gamma ameliorates monocrotaline-induced pulmonary arterial hypertension in rats. Biomed Rep 3:537–542CrossRefPubMedPubMedCentralGoogle Scholar
  67. Xing Y, Zheng X, Li G, Liao L, Cao W, Xing H, Shen T, Sun L, Yang B, Zhu D (2015) MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor beta expression. Int J Biochem Cell Biol 64:155–166CrossRefPubMedGoogle Scholar
  68. Yang S, Banerjee S, Freitas A, Cui H, Xie N, Abraham E, Liu G (2012) miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 302:L521–L529CrossRefPubMedPubMedCentralGoogle Scholar
  69. Yuan P, Wu WH, Gao L, Zheng ZQ, Liu D, Mei HY, Zhang ZL, Jing ZC (2013) Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways. Eur Respir J 41:1116–1125CrossRefPubMedGoogle Scholar
  70. Zeng Y, Liu H, Kang K, Wang Z, Hui G, Zhang X, Zhong J, Peng W, Ramchandran R, Raj JU, Gou D (2015) Hypoxia inducible factor-1 mediates expression of miR-322: potential role in proliferation and migration of pulmonary arterial smooth muscle cells. Sci Rep 5:12098CrossRefPubMedPubMedCentralGoogle Scholar
  71. Zhang D, Wang G, Han D, Zhang Y, Xu J, Lu J, Li S, Xie X, Liu L, Dong L, Li M (2014) Activation of PPAR-gamma ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats. Life Sci 98:39–43CrossRefPubMedGoogle Scholar
  72. Zhang S, Liu F, Mao X, Huang J, Yang J, Yin X, Wu L, Zheng L, Wang Q (2015) Elevation of miR-27b by HPV16 E7 inhibits PPARgamma expression and promotes proliferation and invasion in cervical carcinoma cells. Int J Oncol 47:1759–1766CrossRefPubMedGoogle Scholar
  73. Zhang TT, Cui B, Dai DZ, Su W (2005) CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway. Acta Pharmacol Sin 26:1309–1316CrossRefPubMedGoogle Scholar
  74. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, Yang JM (2008) Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 76:582–588CrossRefPubMedPubMedCentralGoogle Scholar
  75. Zhu Y, Zhang X, Ding X, Wang H, Chen X, Zhao H, Jia Y, Liu S, Liu Y (2014) miR-27 inhibits adipocyte differentiation via suppressing CREB expression. Acta Biochim Biophys Sin 46:590–596CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Xinming Xie
    • 1
  • Shaojun Li
    • 1
  • Yanting Zhu
    • 1
  • Lu Liu
    • 1
  • Yilin Pan
    • 1
  • Jian Wang
    • 1
  • Wenhua Shi
    • 1
  • Yang Song
    • 1
  • Lan Yang
    • 1
  • Li Gao
    • 2
  • Weijin Zang
    • 3
  • Manxiang Li
    • 1
    Email author
  1. 1.Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Medical CollegeXi’an Jiaotong UniversityXi’anPeople’s Republic of China
  2. 2.Division of Allergy and Clinical Immunology, Department of MedicineThe Johns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Department of Pharmacology, School of Basic Medical SciencesXian Jiaotong University Health Science CenterXi’anPeople’s Republic of China

Personalised recommendations